S&P Pharma Dose

Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.

What Bausch RemainCo’s Credit Quality Post-Spinoff Could Look Like 09/21/2020

Regeneron Pharmaceuticals: Steady Growth vs. Heavy Product Concentration 08/05/2020

Episode 34: More Color on PPD’s Rating After IPO 02/11/2020

Episode 33: Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations 01/21/2020

Episode 32: Pfizer Finds Home For Upjohn, Though Lessened Diversity Results In Lower Rating 08/01/2019

Episode 31: Thoughts On Pharma’s Washington Grilling 03/07/2019

Episode 30: Rebates And Pharma Supply Chain 08/03/2018

Episode 29: Just When You Thought It Was Safe to Go Back In the Water - Amazon Buys PillPack 07/11/2018

Episode 28: President Trump's American Patient First Speech - Placebo? 05/18/2018

Episode 27: Bezos, Buffett, and Dimon - Welcome to the Healthcare Party 02/05/2018

Episode 26: Generic Drug Pricing - When Does the Pain Stop? 02/02/2018

Episode 25: Four Things We Are Watching For On Teva 12/07/2017

Episode 24: Et Tu Amazon? Amazon and Impact on Pharma Pricing 11/15/2017

Episode 23: CVS Health Possibly Seeks to Buy Aetna - Surprised? You Shouldn't Be 11/03/2017

Episode 22: Reflections - Mylan NV Earnings 2Q17 09/06/2017

Episode 21: Endo Intl Downgrade to 'B' - Litigation, Generics, and Opioids 08/17/2017

Episode 20: Rite Aid Corp. - What's Next For the Company? 08/16/2017

Episode 19: Reflections - Eli Lilly Earnings 2Q17 07/26/2017

Episode 17: Pharma Outlook in 7 Minutes 06/15/2017

Episode 16: Four Takeaways - Amgen Inc. 06/15/2017

Episode 15: Pharma Chat - CRO Consolidation 06/15/2017

Episode 14: PBMs Still Have a Role? Focus on Express Scripts 04/05/2017

Episode 13: Four Takeaways - Merck & Co. 04/05/2017

Episode 12: Pharma Chat - It's All in the Transparency 02/02/2017

Episode 11: Four Takeaways - Eli Lilly 01/13/2017

Episode 10: U.S. Tax Reform - Positive But Some Near Term Concerns For Pharma Ratings 12/15/2016

Episode 9: Pharma and Trump 11/28/2016

Episode 8: Generic Drug Pricing 11/28/2016

Episode 7: Pharma Chat - Recent Topics 07/22/2016

Episode 6: S&P's Positive Ratings Outlook for CROs - What is driving it? 07/12/2016